Market Tracker

12/14 5:15pm ET

Depomed Inc (NASDAQ:DEPO)

8.16
Delayed Data
As of 4:00pm ET
 -0.29 / -3.43%
Today’s Change
4.31
Today|||52-Week Range
21.38
-54.72%
Year-to-Date

Today’s Trading

Previous close8.45
Today’s open8.48
Day’s range8.04 - 8.52
Volume1,485,027
Average volume (3 months)1,785,804
Market cap$532.5M
Data as of 4:00pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)-15.08%
Earnings growth (this year)-42.67%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+33.02%
P/E ratioNM
Price/Sales2.42
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.10+1.25%
GLYCGlycoMimetics Inc-0.46-2.79%
AVEOAveo Pharmaceuticals...-0.02-0.68%
ACIUAC Immune SA+0.13+1.07%
Data as of 4:00pm ET, 12/14/2017

Financials

Next reporting dateFebruary 20, 2018
EPS forecast (this quarter)$0.12
Annual revenue (last year)$455.9M
Annual profit (last year)-$88.7M
Net profit margin-19.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts